ATHGHIN BIOTECHNOLOGY, INC. — Department of Health and Human Services STTR Phase I: 113
ATHGHIN BIOTECHNOLOGY, INC. — STTR Phase I award from Department of Health and Human Services.
- Amount
- $221,720
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- STTR · Phase I
- Topic
- 113
- Solicitation
- ES15-005
- NAICS
- —
- Place of performance
- NY
- Period
- 2015-09-01 → 2016-08-31
Description
DESCRIPTION provided by applicant The long term objective of this application is to provide a high throughput platform to test the effects of chemical exposure on human brain development In the US chemicals are not required for health or environmental safety testing before their incorporation in consumer products Over registered chemicals are in commerce most of which are used without any information on their long term health effects Considering each one of these one by one is a slow and expensive process Currently there is no system in place to screen compounds in terms of their health consequences before product implementation and with over registered chemicals in commerce a high throughput mechanism to screen these compounds is needed Human pluripotent stem cell hPSC technology offers a manipulatable platform to study the early stages of brain development In a recent study from our lab we adapted a protocol to differentiate hPSCs into cerebral cortical neurons over days that recapitulated each stage of cortical development The cerebral cortex has been shown to be particularly sensitive to chemical exposure during development Preliminary data from our lab show that chemical exposure during the early stages of this protocol lead to changes of key neuro developmental genes at different times during development providing evidence that our in vitro system can be used to assess chemical toxicity Here we propose the development of a high throughput assay using hPSC technology to screen large numbers of chemical compounds by assessing how they alter human brain development This study will develop a cost effective tool to analyze thousands of compounds with a simple PCR assay that can be easily adapted and used by researchers and industries everywhere PUBLIC HEALTH RELEVANCE Many classes of chemicals found in consumer products contribute to chronic health problems in our population In particular evidence has emerged in the last years showing significant effects of chemical exposure on brain development This study aims to create a novel platform to test the effects of chemical exposure on human brain development using stem cell technology allowing for the systematic testing of chemicals before product implementation